The FDA has approved the first heart valve to be implanted by way of a vein in the leg and fed all the way up to the heart. The implant is intended to treat defects in the heart’s pulmonary valve, such as a leak, which a person is born with. The pulmonary valve, which helps manage the system that brings blood from the right ventricle of the heart to the lungs properly, can then operate correctly.
Implantation of the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System will benefit patients with previously implanted valves that are no longer operating correctly by postponing the need for surgery.
The FDA noted that the implant can eventually wear out, requiring a replacement. Also, the valve does not cure a patient’s heart condition, but can allow continued function of the pulmonary valve and delay open heart surgery. Additional studies of the Medtronic system are required by the FDA to clarify the risks and benefits of this implant.
Heart disease is the number one killer in the nation, and failure to diagnose a heart attack is the number one medical malpractice mistake in the U.S. If you or a loved one has been the victim of medical malpractice, please contact the medical malpractice attorneys at Silberstein Awad & Miklos today to schedule your free consultation. We have been helping clients with Brooklyn medical malpractice, Bronx medical malpractice, Queens medical malpractice and Long Island medical malpractice cases since 1981, and we can help you too.
Call us toll-free, 1-877-ASK4SAM and visit www.ask4sam.net
No comments:
Post a Comment